Terms of Use & License Agreement

CRISPR Medicine News (CMN) Global Clinical Trials Database 2.0
Effective Date: 2026-02-17

These Terms of Use (“Terms”) govern access to and use of the CRISPR Medicine News (CMN) Global Clinical Trials Database 2.0 (the “Database”), operated by CRISPR Medicine News (“CMN,” “we,” “us,” or “our”).

By accessing or using this website or the Database, you agree to be bound by these Terms. If you do not agree, you may not access or use the Database.

1. License Grant

Subject to compliance with these Terms, CMN grants users a limited, non-exclusive, non-transferable, revocable license to access and use publicly available portions of the Database for personal, educational, clinical, or non-commercial research purposes.

No ownership rights are transferred under this license.

2. Ownership & Intellectual Property

The Database, including its structure, taxonomy, classifications, curation methodology, annotations, design, organization, and presentation, constitutes proprietary intellectual property owned by CRISPR Medicine News.

While underlying clinical trial information may originate from publicly disclosed sources (including registries, publications, patents, press releases, and company disclosures), the compilation, organization, contextualization, and analytical enhancements represent original editorial and analytical work protected under applicable copyright, database protection, and intellectual property laws.

All third-party trademarks referenced remain the property of their respective owners.

3. Permitted Use

Users may:

  • Search and view Database content

  • Use information for academic citation, internal research, clinical awareness, or non-commercial analysis

  • Cite “CRISPR Medicine News Global Clinical Trials Database 2.0” as the source in publications or presentations

4. Prohibited Conduct

Users may not, without prior written consent from CRISPR Medicine News:

  • Systematically extract, scrape, crawl, mine, harvest, index, or otherwise collect Database content

  • Download, copy, reproduce, redistribute, republish, or publicly display substantial portions of the Database

  • Create derivative databases, datasets, or competing products based on the Database structure, taxonomy, classifications, annotations, or curated framework

  • Use Database content for commercial resale, licensing, competitive intelligence services, automated aggregation, or product development

  • Use Database content to train, fine-tune, validate, benchmark, or populate artificial intelligence (AI) systems, machine learning models, large language models, or other automated decision-making technologies

  • Circumvent or attempt to circumvent technical safeguards, access controls, subscription limitations, rate limits, or security mechanisms

Automated Access & Data Extraction Restrictions

Automated access to the Database, including the use of bots, scripts, crawlers, spiders, scraping tools, AI agents, browser automation tools, or other automated technologies, is strictly prohibited without prior written authorization from CRISPR Medicine News.

Bulk downloading, systematic querying, data harvesting, indexing, mirroring, or extraction intended to replicate, reconstruct, or commercially exploit substantial portions of the Database is expressly prohibited.

CRISPR Medicine News reserves the right to implement technical countermeasures to detect and prevent unauthorized automated access and to pursue all available legal and equitable remedies in response to violations.

close
Search CRISPR Medicine